Featured News
JAN 2023
InterAx Biotech announces the appointment of seasoned pharmaceutical executive, Dr. Christopher Prior, as CEO and reports recent drug discovery highlights.…
JUL 2022
InterAx Biotech, MS Center Amsterdam and the Vrije Universiteit Amsterdam join forces to unlock a novel target to promote remyelination…
SEP 2021
Early and successful completion of European Union’s H2020 Project September 2021, Switzerland Today, InterAx Biotech AG, a Biotech…